Table 4.

Clinical factors of rebleeding within 30 days.

	Univariate analysis			Multivariate analysis
Variable	Clinical success (n0 =0 37)	Rebleeding (n0 =0 22)	P value	Odds ratio	95% CI	P value
Age (years)	64.50 ± 0 18.0	68.60 ± 0 15.2	.371
Male	26 (70.3)	16 (72.7)	.840
Liver cirrhosis	2 (5.4)	5 (22.7)	.065
Renal failure (CRF or ESRD)	5 (13.5)	8 (36.4)	.047	2.79	0.69–11.21	.149
Malignant bleeding	5 (13.5)	2 (9.1)	.614
Coagulopathy*	9 (24.3)	13 (59.1)	.009	3.53	1.07–11.67	.038
Medication†	8 (21.6)	5 (22.7)	.921
Shock	25 (67.6)	20 (90.9)	.056
Embolization time (>24 h)	12 (32.4)	8 (36.4)	.758
Bleeding site (MGI or LGI vs UGI)	19 (51.4)	12 (54.5)	.812
≥2 territories embolization	2 (5.4)	4 (18.2)	.137
Multiple embolic agents	12 (32.4)	3 (13.6)	.119
Massive transfusion‡	5 (13.5)	8 (36.4)	.047	2.36	0.58–9.64	.223